These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 19000887)
1. [Role of anti-HLA antibodies whether or not they are directed against the donor during chronic renal graft dysfunction]. Büchler M Nephrol Ther; 2008 Oct; 4 Suppl 3():S200-3. PubMed ID: 19000887 [TBL] [Abstract][Full Text] [Related]
2. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience. Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J Clin Transpl; 2014; ():223-30. PubMed ID: 26281149 [TBL] [Abstract][Full Text] [Related]
5. Influence of HLA disparity, immunosuppressive regimen used, and type of kidney allograft on production of anti-HLA class-I antibodies after transplant and occurrence of rejection. Abdelnoor AM; Ajib R; Chakhtoura M; Daouk M; Medawar W; Uwaydah M; Sawah SI; Khauli RB Immunopharmacol Immunotoxicol; 2009; 31(1):83-7. PubMed ID: 18752168 [TBL] [Abstract][Full Text] [Related]
6. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies. Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539 [TBL] [Abstract][Full Text] [Related]
14. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients. Meng HL; Jin XB; Li XT; Wang HW; Lü JJ Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748 [TBL] [Abstract][Full Text] [Related]
15. Screening for de novo anti-human leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection. Gill JS; Landsberg D; Johnston O; Shapiro RJ; Magil AB; Wu V; Tinckam K; Keown P Transplantation; 2010 Jan; 89(2):178-84. PubMed ID: 20098280 [TBL] [Abstract][Full Text] [Related]
17. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis. Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738 [TBL] [Abstract][Full Text] [Related]
18. Impacts of donor-specific anti-HLA antibodies and antibody-mediated rejection on outcomes after intestinal transplantation in children. Petit LM; Rabant M; Canioni D; Suberbielle-Boissel C; Goulet O; Chardot C; Lacaille F Pediatr Transplant; 2017 Mar; 21(2):. PubMed ID: 28084679 [TBL] [Abstract][Full Text] [Related]
19. The role of HLA-specific antibodies in kidney transplant rejection: published studies and local data. Worthington JE; Martin S; Barker AJ; McWilliam LJ; Dyer PA Clin Transpl; 2006; ():349-61. PubMed ID: 18365389 [TBL] [Abstract][Full Text] [Related]
20. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies. Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]